Acceleron Pharma Lands $30,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a9156b52-c8b4-4945-958e-014b02e68551&Preview=1 -
Date
12/23/2011 -
Company Name
Acceleron Pharma -
Mailing Address
128 Sidney Street Cambridge, MA 02139 -
Company Description
Acceleron is establishing itself as the premier company in GDF-targeted therapies. We have developed an unparalleled expertise in GDF biology, and our scientific advisory board consists of leaders and pioneers in the field. -
Website
http://www.acceleronpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$30,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The proceeds will be used to expand and advance Acceleron’s clinical stage pipeline and to continue to support its highly productive research engine. -
M&A Terms
-
Venture Investor
Celgene Corporation -
Venture Investor
Advanced Technology Ventures -
Venture Investor
Avalon Ventures -
Venture Investor
Bessemer Venture Partners -
Venture Investor
Flagship Ventures -
Venture Investor
MPM Capital -
Venture Investor
OrbiMed -
Venture Investor
Polaris Venture Partners -
Venture Investor
QVT Fund LP -
Venture Investor
Sutter Hill Ventures -
Venture Investor
Venrock
